-
EP0315289
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0315289
| EP0315289 - Cell growth inhibitory factor [Right-click to bookmark this link] | Status | The application has been refused Status updated on 14.09.1993 Database last updated on 31.08.2024 | Most recent event Tooltip | 14.09.1993 | Refusal of application | published on 03.11.1993 [1993/44] | Applicant(s) | For all designated states ONCOGEN 3005 First Avenue Seattle, WA 98121 / US | [1989/19] | Inventor(s) | 01 /
Rowe, John M. 9091 Olympus Beach Road N.E. Bainbridge Island Washington 98110 / US | 02 /
Shoyab, Mohammed 2405 Westmont Way West Seattle Washington 98199 / US | [1989/19] | Representative(s) | Kinzebach, Werner, et al Reitstötter, Kinzebach & Partner Patentanwälte Postfach 86 06 49 81633 München / DE | [N/P] |
| Former [1989/19] | Kinzebach, Werner, Dr., et al Patentanwälte Reitstötter, Kinzebach und Partner Postfach 86 06 49 D-81633 München / DE | Application number, filing date | 88202611.5 | 04.11.1988 | [1989/19] | Priority number, date | US19870118185 | 06.11.1987 Original published format: US 118185 | [1989/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0315289 | Date: | 10.05.1989 | Language: | EN | [1989/19] | Type: | A3 Search report | No.: | EP0315289 | Date: | 11.04.1990 | Language: | EN | [1990/15] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 19.02.1990 | Classification | IPC: | A61K37/02 | [1989/19] | CPC: |
C07K14/475 (EP);
A61K38/00 (KR);
A61K38/204 (EP);
A61P35/00 (EP);
C07K14/52 (EP)
| C-Set: |
A61K38/204, A61K2300/00 (EP)
| Designated contracting states | AT, BE, CH, DE, ES, FR, GB, GR, IT, LI, LU, NL, SE [1989/19] | Title | German: | Das Zellwachstum inhibierender Faktor | [1989/19] | English: | Cell growth inhibitory factor | [1989/19] | French: | Facteur inhibiteur de croissance cellulaire | [1989/19] | File destroyed: | 12.06.1999 | Examination procedure | 22.08.1990 | Examination requested [1990/42] | 08.04.1991 | Despatch of a communication from the examining division (Time limit: M06) | 18.10.1991 | Reply to a communication from the examining division | 12.11.1991 | Despatch of a communication from the examining division (Time limit: M06) | 22.05.1992 | Reply to a communication from the examining division | 10.12.1992 | Despatch of communication of intention to grant (Approval: ) | 09.06.1993 | Despatch of communication that the application is refused, reason: formalities examination [1993/44] | 19.06.1993 | Application refused, date of legal effect [1993/44] | Fees paid | Renewal fee | 20.11.1990 | Renewal fee patent year 03 | 11.11.1991 | Renewal fee patent year 04 | 09.10.1992 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]NL8603209 ; | [A]EP0217645 (CETUS CORP [US]); | [XP]WO8800206 (GENETICS INST [US]); | [XP]EP0257406 (AJINOMOTO KK [JP], et al); | [XP]WO8806891 (ASTRA AB [SE]) | [A] - CANCER RESEARCH, vol. 42, December 1982, pages 4948-4953; E.C. BORDEN et al.: "Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells" | [A] - INTERNATIONAL JOURNAL OF CANCER, vol. 40, 1987, pages 53-57, Alan R. Liss, Inc.; R. EXLEY et al.: "Anti-proliferative effects of interferons on Daudi Burkitt lymphoma cells: induction of cell differentiation and loss of response to autocrine growth factors" | [A] - JOURNAL OF INTERFERON RESEARCH, vol. 7, no. 6, 1987, page 840, no. III-88; W. POPIK et al.: "Synergistic or antagonistic interactions between interferons and transforming growth factors in antiviral or antimitogenic assays" | [ ] - CHEMICAL ABSTRACTS, vol. 110, no. 1, 02 January 1989, Columbus, OH (US); p. 579, no. 6095w# | [A] - CHEMICAL ABSTRACTS, vol. 110, no. 1, 2nd January 1989, page 579, abstract no. 6095w, Columbus, Ohio, US; & NL-A-86 03 209 (ONCOGEN) 16-07-1987, & NL8603209 A 00000000 | [A] - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 83, December 1986, pages 8957-8961; L.T. MAY et al.: "Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta2 interferon involved" | [A] - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 84, January 1987, pages 228-231; T. HIRANO et al.: "Human beta-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production" | [A] - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 83, September 1986, pages 7059-7063; I. HELLSTR\M et al.: "Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas" | [A] - BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 148, no. 2, 1987, pages 783-789, Academic Press, Inc.; J.E. RANCHALIS et al.: "Bone-derived and recombinant transforming growth factor beta's are potent inhibitors of tumor cell growth" | [XP] - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 85, November 1988, pages 8037-8041; L. CHEN et al.: "Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta2" |